Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of Therapy

W.Y. Leung, Nancy; Lai, Ching-Lung; Chang, Ting-Tsung; Guan, Richard; Lee, Chuan-Mo; Ng, Keng-Yeen; Lim, Seng-Gee; Wu, Pui-Chee; C. Dent, Julie; Edmundson, Sally; D. Condreay, Lynn; Chien, Rong-Nan

doi:10.1053/jhep.2001.25084

Public

Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of Therapy

Shared by NobleBlocks on Jun 1, 2001 • 12:00 AM UTC

Authors:

Nancy W.Y. Leung

Ching-Lung Lai

Ting-Tsung Chang

Abstract

A study in Chinese patients with chronic hepatitis B showed that treatment with lamivudine for 1 year significantly improves liver histology and enhances hepatitis B e antigen (HBeAg) seroconversion compared with placebo. Fifty–eight patients from this 1–year study have received long–term treatment ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!